Works matching DE "FEXOFENADINE"

Results: 287

Application of green first derivative synchronous spectrofluorometric method for quantitative analysis of fexofenadine hydrochloride and pseudoephedrine hydrochloride in pharmaceutical preparation and spiked human plasma.

Published in:

BMC Chemistry, 2022, v. 16, n. 1, p. 1, doi. 10.1186/s13065-022-00855-5

By:

Ramzy, Sherif;
Abdelazim, Ahmed H.;
Hasan, Mohamed A.

Publication type:

Article

New pencil graphite electrodes for potentiometric determination of fexofenadine hydrochloride and montelukast sodium in their pure, synthetic mixtures, and combined dosage form.

Published in:

BMC Chemistry, 2020, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13065-020-00716-z

By:

Nashed, Dania;
Noureldin, Imad;
Sakur, Amir Alhaj

Publication type:

Article

An Interesting COVID-19 Case.

Published in:

Family Doctor: A Journal of the New York State Academy of Family Physicians, 2021, v. 10, n. 1, p. 25

By:

Bajwa, Jasdeep Singh;
Jingnan Bu

Publication type:

Article

Fexofenadine/Cyclodextrin Inclusion Complexation: Phase Solubility, Thermodynamic, Physicochemical, and Computational Analysis.

Published in:

Drug Development & Industrial Pharmacy, 2007, v. 33, n. 11, p. 1205, doi. 10.1080/03639040701377672

By:

Al Omari, Mahmoud M.;
Badwan, Adnan A.;
Zughul, Mohammad B.;
Davies, J. Eric D.

Publication type:

Article

Determination of Fexofenadine in Tablets by Capillary Electrophoresis in Free Solution and in Solution with Cyclodextrins as Analyte Carriers.

Published in:

Drug Development & Industrial Pharmacy, 2005, v. 31, n. 8, p. 795, doi. 10.1080/03639040500217368

By:

Mikuš, Peter;
Valášková, Iva;
Havránek, Emil

Publication type:

Article

Data mining in FAERS: association of newer-generation H1-antihistamines with nervous system disorders.

Published in:

BMC Pharmacology & Toxicology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s40360-024-00822-x

By:

Hu, Weiping;
Li, Hailong;
Zeng, Linan;
Gan, Jing;
Feng, Chenghong;
Chen, Li;
Zhang, Lingli

Publication type:

Article

Bioequivalence of 2 Pediatric Formulations of Fexofenadine Hydrochloride Oral Suspension.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 12, p. 1194, doi. 10.1002/cpdd.1311

By:

Rauch, Clemence;
Lucio, Luiz;
De Fer, Beatrice Bois;
Lheritier‐Barrand, Michele

Publication type:

Article

Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2015, v. 40, n. 1, p. 98, doi. 10.1111/jcpt.12213

By:

Akamine, Y.;
Miura, M.;
Yasui‐Furukori, N.;
Ieiri, I.;
Uno, T.

Publication type:

Article

Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2010, v. 35, n. 2, p. 169, doi. 10.1111/j.1365-2710.2009.01159.x

By:

Yamazaki, A.;
Kumagai, Y.;
Yamane, N.;
Tozuka, Z.;
Sugiyama, Y.;
Fujita, T.;
Yokota, S.;
Maeda, M.

Publication type:

Article

Impact of ABCB1 genotype in Collies on the pharmacokinetics of R‐ and S‐fexofenadine.

Published in:

Journal of Veterinary Pharmacology & Therapeutics, 2018, v. 41, n. 6, p. 805, doi. 10.1111/jvp.12696

By:

Myers, Michael J.;
Martinez, Marilyn;
Li, Fei;
Howard, Karyn;
Yancy, Haile F.;
Troutman, Lisa;
Sharkey, Michele

Publication type:

Article

Efficacy of Naproxen/Fexofenadine (SJP-003) in the Prevention of Side Effects of Influenza Vaccination: Four Case Studies.

Published in:

2022

By:

Kiani, Pantea;
Dahl, Thomas A.;
Iversen, Jacqueline M.;
Scholey, Andrew;
Verster, Joris C.

Publication type:

Case Study

THE EFFECT OF TERFENADINE, FEXOFENADINE AND E4031 IN ISOLATED AND PERFUSSED GUINEA-PIG HEARTS.

Published in:

British Journal of Pharmacology, 2003, v. 140, p. 40P

By:

Maginn, M.;
Åkerlund, O.;
Matz, J.

Publication type:

Article

Addition of oral fexofenadine to topical therapy leads to a significantly greater reduction in the serum interleukin‐31 levels in mild to moderate paediatric atopic dermatitis.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 4, p. 724, doi. 10.1111/ced.15032

By:

Ningombam, A.;
Handa, S.;
Srivastava, N.;
Mahajan, R.;
De, D.

Publication type:

Article

Flexural follicular lichen planus.

Published in:

2009

By:

Gunduz, K.;
Sacar, T.;
Inanir, I.;
Demireli, P.

Publication type:

Letter

Concurrent Discriminative Emission Intensity Quantification of Fexofenadine hydrochloride and Montelukast Sodium.

Published in:

Oriental Journal of Chemistry, 2022, v. 38, n. 6, p. 1364, doi. 10.13005/ojc/380605

By:

ANUMOLU, PANIKUMAR DURGA;
SHAKAR, PULUSU VEERA;
TULASI, JAMPANA RAMA;
SOUJANYA, CHAGANTI;
AFREEN, SYED SARA;
ASHOK, GORJA

Publication type:

Article

Formulation, ex-vivo and in-vitro characterization of liposomal drug delivery system of Fexofenadine.

Published in:

Thai Journal of Pharmaceutical Sciences, 2022, v. 46, n. 1, p. 56

By:

Shrestha, Safin;
Budhathoki, Uttam

Publication type:

Article

APPLICATION OF SDS MICELLES AS CARRIERS FOR RELIABLE DETERMINATION OF FEXOFENADINE AND ITS IMPURITIES IN BULK AND PHARMACEUTICAL FORMULATIONS BY CAPILLARY MICELLAR ELCETROPHORESIS.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2014, v. 37, n. 1, p. 112, doi. 10.1080/10826076.2012.738615

By:

Javid, FarinSattary;
Shafaati, Alireza;
Zarghi, Afshin

Publication type:

Article

An Innovative Spectrophotometric Method for the Estimation of H<sub>1</sub> Receptor Antagonists in Pharmaceutical Formulations.

Published in:

Indian Journal of Pharmaceutical Sciences, 2021, v. 83, n. 5, p. 939, doi. 10.36468/pharmaceutical-sciences.846

By:

PATEL, BHOOMI;
PATEL, S.

Publication type:

Article

Assessment of Bioequivalence of Fexofenadine and Montelukast Fixed Dose Combination Tablet Versus Separate Formulations of the Individual Components at the Same Dose Levels.

Published in:

Indian Journal of Pharmaceutical Sciences, 2016, v. 78, n. 5, p. 651, doi. 10.4172/pharmaceutical-sciences.1000164

By:

WALEKAR, A.;
CHODANKAR, D.;
NAQVI, M.;
TRIVEDI, C.

Publication type:

Article

Taste Masked Orodispersible Formulation of Fexofenadine Hydrochloride Using Ion Exchange Resins.

Published in:

Indian Journal of Pharmaceutical Sciences, 2015, v. 77, n. 5, p. 550, doi. 10.4103/0250-474X.169027

By:

SUARES, DIVYA;
HIRAY, ARTI

Publication type:

Article

Does Ethnic Variability Exist in the Systemic Exposures of OATP1A2 Substrates-Fexofenadine in Taiwanese?

Published in:

Indian Journal of Pharmaceutical Sciences, 2015, v. 77, n. 5, p. 573, doi. 10.4103/0250-474X.169032

By:

CHEN, Y. A.;
JUAN, C. H.;
HSU, K. Y.

Publication type:

Article

Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 627, doi. 10.1002/cpt.2682

By:

Misaka, Shingen;
Ono, Yuko;
Taudte, R. Verena;
Hoier, Eva;
Ogata, Hiroshi;
Ono, Tomoyuki;
König, Jörg;
Watanabe, Hiroshi;
Fromm, Martin F.;
Shimomura, Kenju

Publication type:

Article

Randomized Double-Blind Comparison of Cetirizine and Fexofenadine after Pollen Challenge in the Environmental Exposure Unit: Duration of Effect in Subjects with Seasonal Allergic Rhinitis.

Published in:

Allergy & Asthma Proceedings, 2004, v. 25, n. 1, p. 59

By:

Day, James H.;
Briscoe, Maureen P.;
Rafeiro, Elizabeth;
Hewlett Jr., Dial;
Chapman, Douglass;
Kramer, Benjamin

Publication type:

Article

Research Abstracts from the SWAF/EAC/TAAIS Combined Meeting, Puerto Vallarta, Mexico, January 19, 2003.

Published in:: 2003
Publication type:: Abstract

A simulated car-driving study on the effects of acute administration of levocetirizine, fexofenadine, and diphenhydramine in healthy Japanese volunteers.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 3, p. 167, doi. 10.1002/hup.2524

By:

Inami, Akie;
Matsuda, Rin;
Grobosch, Thomas;
Komamura, Hiroshi;
Takeda, Kazuko;
Yamada, Yusuke;
Miyake, Masayasu;
Hiraoka, Kotaro;
Maurer, Marcus;
Yanai, Kazuhiko;
Tashiro, Manabu

Publication type:

Article

Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2005, v. 20, n. 7, p. 501, doi. 10.1002/hup.713

By:

Tashiro, Manabu;
Horikawa, Etsuo;
Mochizuki, Hideki;
Sakurada, Yumiko;
Kato, Motohisa;
Inokuchi, Takatoshi;
Ridout, Fran;
Hindmarch, Ian;
Yanai, Kazuhiko

Publication type:

Article

Comparative study of acute effects of single doses of fexofenadine, olopatadine, d -chlorpheniramine and placebo on psychomotor function in healthy volunteers.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2003, v. 18, n. 8, p. 611, doi. 10.1002/hup.538

By:

Kamei, Hiroyuki;
Noda, Yukihiro;
Ishikawa, Kazuhiro;
Senzaki, Koji;
Muraoka, Isao;
Hasegawa, Yoshinori;
Hindmarch, Ian;
Nabeshima, Toshitaka

Publication type:

Article

Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 9, p. 1087, doi. 10.1007/s00228-014-1705-y

By:

Akamine, Yumiko;
Miura, Masatomo;
Komori, Hisakazu;
Saito, Shun;
Kusuhara, Hiroyuki;
Tamai, Ikumi;
Ieiri, Ichiro;
Uno, Tsukasa;
Yasui-Furukori, Norio

Publication type:

Article

Effect of metronidazole on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy male volunteers.

Published in:

European Journal of Clinical Pharmacology, 2010, v. 66, n. 7, p. 721, doi. 10.1007/s00228-010-0797-2

By:

Kim, Kyoung-Ah;
Park, Ji-Young

Publication type:

Article

Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers.

Published in:

European Journal of Clinical Pharmacology, 2009, v. 65, n. 6, p. 609, doi. 10.1007/s00228-009-0627-6

By:

Kyoung-Ah Kim;
Pil-Whan Park;
Ji-Young Park

Publication type:

Article

Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997.

Published in:

European Journal of Clinical Pharmacology, 2001, v. 57, n. 4, p. 313, doi. 10.1007/s002280100292

By:

Craig-McFeely, Patrick M.;
Acharya, Nayan V.;
Shakir, Saad A.

Publication type:

Article

Effficacy and Safety of Fexofenadine and Montelukast Combination Therapy in Allergic Rhinitis Management: A Systematic Review.

Published in:

ENT Updates, 2024, v. 14, n. 3, p. 111, doi. 10.54963/entu.v14i3.874

By:

Alqathanin, Wajan;
Alshammari, Hani;
Alqattan, Zahra;
Allwaish, Layaly;
Alhemaidi, Norah;
Albathali, Eman;
Alruwaili, Tahani;
Alharbi, Riyadh;
Akshah, Abdulrahman;
Aljali, Refal;
Alasmari, Yasser;
Alnami, Awatif;
Alzahrani, Abdullah;
Abdullah, Leen;
Alkhowailed, Khluod;
Kanan, Mohammed

Publication type:

Article

10. Inflammatory.

Published in:: 2003
Publication type:: Abstract

Solid Form and Phase Transformation Properties of Fexofenadine Hydrochloride during Wet Granulation Process.

Published in:

Pharmaceutics, 2021, v. 13, n. 6, p. 802, doi. 10.3390/pharmaceutics13060802

By:

Li, Suye;
Wu, Hengqian;
Zhao, Yanna;
Zhang, Ruiyan;
Wang, Zhengping;
Han, Jun

Publication type:

Article

Improved Dissolution Rate and Intestinal Absorption of Fexofenadine Hydrochloride by the Preparation of Solid Dispersions: In Vitro and In Situ Evaluation.

Published in:

Pharmaceutics, 2021, v. 13, n. 3, p. 310, doi. 10.3390/pharmaceutics13030310

By:

Eedara, Basanth Babu;
Nyavanandi, Dinesh;
Narala, Sagar;
Veerareddy, Prabhakar Reddy;
Bandari, Suresh;
Khutoryanskiy, Vitaliy

Publication type:

Article

Effect of Rumex Acetosa Extract, a Herbal Drug, on the Absorption of Fexofenadine.

Published in:

Pharmaceutics, 2020, v. 12, n. 6, p. 547, doi. 10.3390/pharmaceutics12060547

By:

Ahn, Jung Hwan;
Kim, Junhyeong;
Rehman, Naveed Ur;
Kim, Hye-Jin;
Ahn, Mi-Jeong;
Chung, Hye Jin

Publication type:

Article

Quality by Design for the Development and Analysis of Enhanced In-Situ Forming Vesicles for the Improvement of the Bioavailability of Fexofenadine HCl In Vitro and In Vivo.

Published in:

Pharmaceutics, 2020, v. 12, n. 5, p. 409, doi. 10.3390/pharmaceutics12050409

By:

Nasr, Ali M.;
Qushawy, Mona K.;
Elkhoudary, Mahmoud M.;
Gawish, Aya Y.;
Elhady, Sameh S.;
Swidan, Shady A.

Publication type:

Article

Simultaneous quantitation of Ofloxacin, Fexofenadine HCl and Diclofenac Potassium in affixed dose combinative formulation by HPLC-UV method.

Published in:

Pakistan Journal of Pharmaceutical Sciences, 2015, v. 28, n. 6, p. 1979

By:

Salam, Faseeh Abdus;
Shoaib, Muhammad Harris;
Yousuf, Rabia Ismail;
Sultan, Faisal;
Khan, Muhammad Atif;
Manzoor, Saeed

Publication type:

Article

Correction: Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis.

Published in:

2022

By:

Meltzer, Eli O.;
Rosario, Nelson Augusto;
Van Bever, Hugo;
Lucio, Luiz

Publication type:

Correction Notice

Correction to: Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride.

Published in:

2022

By:

Ansotegui, Ignacio J.;
Bernstein, Jonathan A.;
Canonica, Giorgio W.;
Gonzalez-Diaz, Sandra N.;
Martin, Bryan L.;
Morais-Almeida, Mario;
Murrieta-Aguttes, Margarita;
Sanchez Borges, Mario

Publication type:

Correction Notice

Correction to: Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride.

Published in:

2022

By:

Ansotegui, Ignacio J.;
Bernstein, Jonathan A.;
Canonica, Giorgio W.;
Gonzalez-Diaz, Sandra N.;
Martin, Bryan L.;
Morais-Almeida, Mario;
Murrieta-Aguttes, Margarita;
Sanchez Borges, Mario

Publication type:

Correction Notice

Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride.

Published in:

Allergy, Asthma & Clinical Immunology, 2022, v. 18, n. 1, p. 1, doi. 10.1186/s13223-022-00677-z

By:

Ansotegui, Ignacio J.;
Bernstein, Jonathan A.;
Canonica, Giorgio W.;
Gonzalez-Diaz, Sandra N.;
Martin, Bryan L.;
Morais-Almeida, Mario;
Murrieta-Aguttes, Margarita;
Sanchez Borges, Mario

Publication type:

Article

Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride.

Published in:

Allergy, Asthma & Clinical Immunology, 2022, v. 18, n. 1, p. 1, doi. 10.1186/s13223-022-00677-z

By:

Ansotegui, Ignacio J.;
Bernstein, Jonathan A.;
Canonica, Giorgio W.;
Gonzalez-Diaz, Sandra N.;
Martin, Bryan L.;
Morais-Almeida, Mario;
Murrieta-Aguttes, Margarita;
Sanchez Borges, Mario

Publication type:

Article

Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis.

Published in:

Allergy, Asthma & Clinical Immunology, 2021, v. 17, n. 1, p. 1, doi. 10.1186/s13223-021-00614-6

By:

Meltzer, Eli O.;
Rosario, Nelson Augusto;
Van Bever, Hugo;
Lucio, Luiz

Publication type:

Article

Thank you to reviewers.

Published in:: Xenobiotica, 2024, v. 54, n. 1, p. I, doi. 10.1080/00498254.2024.2303194
Publication type:: Article

Thank you to reviewers.

Published in:: Xenobiotica, 2022, v. 52, n. 4, p. 432, doi. 10.1080/00498254.2022.2062146
Publication type:: Article

Effects of breviscapine and C3435T MDR1 gene polymorphism on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers.

Published in:

Xenobiotica, 2021, v. 51, n. 3, p. 366, doi. 10.1080/00498254.2020.1857467

By:

Zhao, Yingying;
Miao, Zhimin;
Jiang, Mingzhao;
Zhou, Xuan;
Lai, Yong

Publication type:

Article

Bergamottin can be used to assess CYP3A-mediated intestinal first-pass metabolism without affecting P-glycoprotein-mediated efflux in rats.

Published in:

Xenobiotica, 2020, v. 50, n. 4, p. 401, doi. 10.1080/00498254.2019.1644389

By:

Suzuki, Kei;
Taniyama, Kazuhiro;
Aoyama, Takao;
Watanabe, Yoshiaki

Publication type:

Article

ISMP Adverse Drug Reactions: Propofol-Related Infusion Syndrome (PRIS)<sup>1,2</sup>; Ivermectin-Induced Stevens-Johnson Syndrome; Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis From Fexofenadine; Memantine-Related Drug Eruption.

Published in:

Hospital Pharmacy, 2018, v. 53, n. 4, p. 220, doi. 10.1177/0018578718776857

By:

Mancano, Michael A.

Publication type:

Article

Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery.

Published in:

Journal of Cerebral Blood Flow & Metabolism, 2014, v. 34, n. 4, p. 699, doi. 10.1038/jcbfm.2014.4

By:

Thompson, Brandon J;
Sanchez-Covarrubias, Lucy;
Slosky, Lauren M;
Zhang, Yifeng;
Laracuente, Mei-li;
Ronaldson, Patrick T

Publication type:

Article